Cohort 4 data demonstrated positive safety and efficacy results, including additional clinical benefit observed following ...

MTVA READ THE FULL MTVA RESEARCH REPORT Business Update Positive Results for 8-week 48 mg Cohort in Phase 1b Trial of DA-1726 ...

This article describes the trajectory of adherence patterns among users of sodium-glucose cotransporter 2 (SGLT2) inhibitors. The authors found that baseline factors were unable to predict the ...

Background IBD is characterised by recurrent flares, but evidence on whether modifiable dietary factors influence flare risk ...